Literature DB >> 23886614

Meta-analysis of the additional value of integrated 18FDG PET-CT for tumor distant metastasis staging: comparison with 18FDG PET alone and CT alone.

Guangfeng Gao1, Biyan Gong, Wen Shen.   

Abstract

BACKGROUND: We performed a meta-analysis to compare the diagnostic performance of integrated (18)FDG PET-CT with that of (18)FDG PET alone and CT alone for the overall assessment of tumor distant metastases.
METHODS: We performed a meta-analysis of 11 available articles (1107 patients). We calculated sensitivities, specificities, positive likelihood ratios, and negative likelihood ratios for integrated PET-CT, PET alone, and CT alone, respectively. We also constructed summary receiver operating characteristic curves for integrated PET-CT, PET alone, and CT alone, respectively.
RESULTS: Across 10 comparative studies (1058 patients), integrated PET-CT has higher sensitivity (0.95 vs 0.85) and similar specificity (0.96 vs 0.95) with PET alone. Across 7 comparative studies (745 patients), integrated PET-CT has higher sensitivity (0.97 vs 0.80) and similar specificity (0.97 vs 0.94) with CT alone.
CONCLUSION: Integrated PET-CT is the most sensitive and accurate modality for tumor distant metastasis staging. Integrating PET with CT may tend to improve the sensitivity than PET alone and CT alone.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Computed tomography; Distant metastasis staging; Neoplasms; Positron emission tomography

Mesh:

Substances:

Year:  2013        PMID: 23886614     DOI: 10.1016/j.suronc.2013.06.004

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  7 in total

Review 1.  Precision Nuclear Medicine: The Evolving Role of PET in Melanoma.

Authors:  Chadwick L Wright; Eric D Miller; Carlo Contreras; Michael V Knopp
Journal:  Radiol Clin North Am       Date:  2021-09       Impact factor: 1.947

2.  Ultrasound, CT, MRI, or PET-CT for staging and re-staging of adults with cutaneous melanoma.

Authors:  Jacqueline Dinnes; Lavinia Ferrante di Ruffano; Yemisi Takwoingi; Seau Tak Cheung; Paul Nathan; Rubeta N Matin; Naomi Chuchu; Sue Ann Chan; Alana Durack; Susan E Bayliss; Abha Gulati; Lopa Patel; Clare Davenport; Kathie Godfrey; Manil Subesinghe; Zoe Traill; Jonathan J Deeks; Hywel C Williams
Journal:  Cochrane Database Syst Rev       Date:  2019-07-01

3.  FDG PET/CT in cancer: comparison of actual use with literature-based recommendations.

Authors:  Henrik Petersen; Paw Christian Holdgaard; Poul Henning Madsen; Lene Meldgaard Knudsen; Dorte Gad; Anders Eggert Gravergaard; Max Rohde; Christian Godballe; Bodil Elisabeth Engelmann; Karsten Bech; Dorte Teilmann-Jørgensen; Ole Mogensen; Jens Karstoft; Jørgen Johansen; Janne Buck Christensen; Allan Johansen; Poul Flemming Høilund-Carlsen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-30       Impact factor: 9.236

4.  The role of FDG-PET/CT in preoperative staging of sentinel lymph node biopsy-positive melanoma patients.

Authors:  Evan C Frary; Dorte Gad; Lars Bastholt; Søren Hess
Journal:  EJNMMI Res       Date:  2016-10-05       Impact factor: 3.138

5.  A mature cystic teratoma adherent to the vaginal wall: a case report.

Authors:  Jian Qiu; Jiewei Xu; Guorong Yao; Mingyue Cao; Fengjia Zhu; Xiaohong Huang
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

Review 6.  Metastatic pancreatic cancer: Mechanisms and detection (Review).

Authors:  Xiangling Chen; Fangfang Liu; Qingping Xue; Xiechuan Weng; Fan Xu
Journal:  Oncol Rep       Date:  2021-09-09       Impact factor: 3.906

Review 7.  Stereotactic radiotherapy for lung oligometastases.

Authors:  Lorenzo Falcinelli; Claudia Menichelli; Franco Casamassima; Cynthia Aristei; Simona Borghesi; Gianluca Ingrosso; Lorena Draghini; Angiolo Tagliagambe; Serena Badellino; Michela Buglione di Monale E Bastia
Journal:  Rep Pract Oncol Radiother       Date:  2022-03-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.